Advertisement
Home »

Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial.

Apr 24, 2023

ABOUT THE EXPERTS

  • Benjamin H Kann

    Department of Radiation Oncology, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA. Electronic address: benjamin_kann@dfci.harvard.edu.

    Jirapat Likitlersuang

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA.

    Dennis Bontempi

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA.

    Zezhong Ye

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA.

    Sanjay Aneja

    Department of Therapeutic Radiology, New Haven, CT, USA.

    Richard Bakst

    Icahn School of Medicine at Mount Sinai, New York, NY, USA.

    Hillary R Kelly

    Mass Eye and Ear, Mass General Hospital, Boston, MA, USA.

    Amy F Juliano

    Mass Eye and Ear, Mass General Hospital, Boston, MA, USA.

    Sam Payabvash

    Department of Radiology, New Haven, CT, USA.

    Jeffrey P Guenette

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.

    Ravindra Uppaluri

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.

    Danielle N Margalit

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.

    Jonathan D Schoenfeld

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.

    Roy B Tishler

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.

    Robert Haddad

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.

    Hugo J W L Aerts

    Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA; Department of Radiology, Maastricht University, Maastricht, Netherlands.

    Joaquin J Garcia

    Department of Pathology, Mayo Clinic, Rochester, MN, USA.

    Yael Flamand

    Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA, USA.

    Rathan M Subramaniam

    Department of Radiology and Nuclear Medicine, University of Notre Dame Australia, Sydney, NSW, Australia; Department of Radiology, Duke University, Durham, NC, USA.

    Barbara A Burtness

    Yale School of Medicine, New Haven, CT, USA.

    Robert L Ferris

    Department of Otolaryngology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement